Key result
Cetuximab combined with FP therapy was associated with the development of pulmonary thromboembolism in a 57-year-old man with mandibular gingival squamous cell carcinoma, which resolved with anticoagulation.
Case Report (n=1)
Prompt antithrombotic therapy can successfully resolve pulmonary thromboembolism associated with cetuximab and FP therapy, allowing for subsequent curative cancer surgery.
Answers are grounded in this paper and cite their sources.
May warrant thromboembolism vigilance during cetuximab-FP for advanced oral cancer; Level 5 case leaves open prophylaxis trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Naruse et al. (2022) conducted a case report in Squamous cell carcinoma of the mandibular gingiva (n=1). Cetuximab with FP therapy (cisplatin and 5-fluorouracil) was evaluated on Development of pulmonary thromboembolism. Cetuximab combined with FP therapy was associated with the development of pulmonary thromboembolism in a 57-year-old man with mandibular gingival squamous cell carcinoma, which resolved with anticoagulation.
Synapse has enriched 10 related papers. Consider them for comparative context: